Cecilia Canales
Datos Biográficos
| ID | 4440305 |
|---|---|
| NOMBRE | Cecilia Canales |
| NOMBRES | Cecilia |
| APELLIDO | Canales |
| FIRMA | CANALES C |
| AFILIACIONES | Instituto de Salud Pública de Chile |
| ORCID | 0000-0002-8839-5689 |
| VERIFICADO | Sí |
| TOTAL DE OBRAS | 2 |
| TOTAL DE CITAS | 0 |
| TOTAL COMO AUTOR | 2 |
| TOTAL COMO EDITOR | 0 |
| PRIMER AÑO DE PUBLICACIÓN | 2023 |
| AÑO MÁS RECIENTE DE PUBLICACIÓN | 2024 |
| ÍNDICE H | 0 |
Rate estimation and trend analysis of new HIV infections among the international migrant population in Chile from 2013 to 2022
HIV incidence rates were higher in international migrants than in Chileans and increased over the study period. This may be influenced by various exogenous factors, including social determinants of health and the COVID-19 pandemic. It is crucial to focus on HIV diagnosis, prevention, and control strategies for international migrants in Chile
Humoral immunity against Sars-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
Introduction: Severe acute respiratory syndrome virus 2 (SARS-CoV-2) has caused over million deaths worldwide, with more than 61,000 deaths in Chile. The Chilean government has implemented a vaccination program against SARS-CoV-2, with over 17.7 million people receiving a complete vaccination scheme. The final target is 18 million individuals. The most common vaccines used in Chile are CoronaVac (Sinovac) and BNT162b2 (Pfizer-Biotech). Given the …
Sin obras prominentes en esta página.
Humoral immunity against Sars-CoV-2 evoked by heterologous vaccination groups using the CoronaVac (Sinovac) and BNT162b2 (Pfizer/BioNTech) vaccines in Chile
Introduction: Severe acute respiratory syndrome virus 2 (SARS-CoV-2) has caused over million deaths worldwide, with more than 61,000 deaths in Chile. The Chilean government has implemented a vaccination program against SARS-CoV-2, with over 17.7 million people receiving a complete vaccination scheme. The final target is 18 million individuals. The most common vaccines used in Chile are CoronaVac (Sinovac) and BNT162b2 (Pfizer-Biotech). Given the …
Rate estimation and trend analysis of new HIV infections among the international migrant population in Chile from 2013 to 2022
HIV incidence rates were higher in international migrants than in Chileans and increased over the study period. This may be influenced by various exogenous factors, including social determinants of health and the COVID-19 pandemic. It is crucial to focus on HIV diagnosis, prevention, and control strategies for international migrants in Chile
Medicine (2 obras) · Virology (2 obras) · Antibody (1 obras) · Antibody response (1 obras) · COVID-19 Clinical Research Studies (1 obras) · Demography (1 obras) · Demography (1 obras) · Econometrics (1 obras) · Economics (1 obras) · Environmental health (1 obras)